Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Cheetham

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|December 1, 1993
Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptorS C Cheetham, D J Heal
Journal of Neural Transmission. General Section|January 1, 1989
[3H]5-HT binding in post-mortem human cerebral cortex: methodological considerationsS C Cheetham, R W Horton
The European Journal of Neuroscience|January 19, 2005
Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behavioursE L Lane, S C Cheetham, P Jenner
Neuropharmacology|October 1, 1989
[3H]5-hydroxytryptamine binding sites in postmortem human brainS C Cheetham, Y Yamaguchi, R W Horton
Experimental Neurology|July 12, 2005
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?E L Lane, S C Cheetham, P Jenner
Neuropharmacology|September 19, 2009
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safetyD J Heal, S C Cheetham, S L Smith
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
European Journal of Pharmacology|August 29, 1989
Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177F De Paermentier, S C Cheetham, M R Crompton, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|December 1, 1993
Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptorS C Cheetham, D J Heal
Journal of Neural Transmission. General Section|January 1, 1989
[3H]5-HT binding in post-mortem human cerebral cortex: methodological considerationsS C Cheetham, R W Horton
The European Journal of Neuroscience|January 19, 2005
Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behavioursE L Lane, S C Cheetham, P Jenner
Neuropharmacology|October 1, 1989
[3H]5-hydroxytryptamine binding sites in postmortem human brainS C Cheetham, Y Yamaguchi, R W Horton
Experimental Neurology|July 12, 2005
Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?E L Lane, S C Cheetham, P Jenner
Neuropharmacology|September 19, 2009
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safetyD J Heal, S C Cheetham, S L Smith
Pharmacology, Biochemistry, and Behavior|August 1, 1995
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatmentsK F Martin, I Phillips, S C Cheetham, et al.
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
European Journal of Pharmacology|August 29, 1989
Beta-adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177F De Paermentier, S C Cheetham, M R Crompton, et al.
Pageof 4